IL1R2 and prostate carcinoma: Among U.S. men, two inflammatory-related sequence variants, [IL1R2 rs11886877 (GA, GA + AA, AA) and IL10RA rs4252243 AA], were associated with a 1.82-2.49-fold increase in prostate cancer risk.